In February Mobisante announced that the FDA had cleared its handheld, smartphone-enabled ultrasound offering, and while the company hoped to launch "a long time ago," MobiUS only just became commercially available in recent days, Mobisante co-founder and CTO David Zar told MobiHealthNews.
Since it received its 510(k) clearance eight months ago, Mobisante has been working to put its quality...
